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Major depressive disorder (MDD) is marked by disturbances in brain functional
connectivity. This connectivity is modulated by rhythmic oscillations of brain electrical
activity, which enable coordinated functions across brain regions. Oscillatory activity
plays a central role in regulating thinking and memory, mood, cerebral blood flow,
and neurotransmitter levels, and restoration of normal oscillatory patterns is associated
with effective treatment of MDD. Repetitive transcranial magnetic stimulation (rTMS)
is a robust treatment for MDD, but the mechanism of action (MOA) of its benefits
for mood disorders remains incompletely understood. Benefits of rTMS have been
tied to enhanced neuroplasticity in specific brain pathways. We summarize here the
evidence that rTMS entrains and resets thalamocortical oscillators, normalizes regulation
and facilitates reemergence of intrinsic cerebral rhythms, and through this mechanism
restores normal brain function. This entrainment and resetting may be a critical step in
engendering neuroplastic changes and the antidepressant effects of rTMS. It may be
possible to modify the method of rTMS administration to enhance this MOA and achieve
better antidepressant effectiveness. We propose that rTMS can be administered: (1)
synchronized to a patient’s individual alpha frequency (IAF), or synchronized rTMS (sTMS);
(2) as a low magnetic field strength sinusoidal waveform; and, (3) broadly to multiple brain
areas simultaneously. We present here the theory and evidence indicating that these
modifications could enhance the therapeutic effectiveness of rTMS for the treatment
of MDD.
Keywords: rTMS, sTMS, major depressive disorder, individual alpha frequency, mechanism of action of TMS
INTRODUCTION
The technique of transcranial magnetic stimulation (TMS) has
its roots in brain neurophysiology. The technique is based on
Faraday’s principles of electromagnetic induction, and was first
reported as a method for inducing currents in the human brain
in 1985 (Barker et al., 1985). The electric potential associated with
this brain current can be sufficient to depolarize neurons inmotor
cortex and generate a motor evoked potential (MEP). TMS sub-
sequently has been shown to have robust and reproducible effects
on perception and cognition, which have been posited to occur
through creation of “virtual lesions” (Pascual-Leone et al., 2000).
Repetitive pulses of TMS, or repetitive transcranial magnetic
stimulation (rTMS), was first demonstrated to be an effective
therapeutic modality for major depressive disorder (MDD) in the
mid-1990s (George and Wassermann, 1994; George et al., 1995;
Pascual-Leone et al., 1996) and, over the past two decades, it
repeatedly has been demonstrated to have therapeutic benefit for
MDD (George et al., 2000, 2010; Dannon and Grunhaus, 2001;
Grunhaus et al., 2002, 2003; Prudic et al., 2004; O’Reardon et al.,
2007; Higgins and George, 2009; Shutter, 2009; Slotema et al.,
2010; Carpenter et al., 2012). The enduring effects of rTMS on
mood are consistent with the observed effects of repetitive stim-
ulation on brain function, which has been reported to last for
minutes to days after the termination of stimulation and extend
well beyond the site of stimulation, suggesting sustained effects
on excitability and plasticity of neuronal circuits (Siebner and
Rothwell, 2003).
Evidence suggests that the effectiveness of rTMS in treating
MDD may be based upon the effects of the technique in altering
brain oscillatory activity and connectivity. We review below evi-
dence regarding abnormal brain neurophysiology in MDD, the
neurophysiologic effects of TMS and rTMS, how these effects
might be related to the therapeutic mechanism of action (MOA)
of rTMS in MDD, and then finally propose a novel approach to
rTMS treatment based upon an understanding of brain neuro-
physiology in MDD.
BRAIN CONNECTIVITY AND OSCILLATORY ACTIVITY IN MDD
MDD involves dysfunction in a number of cortical regions,
such as dorsolateral prefrontal cortex (DLPFC) and anterior
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cingulate cortex (ACC), as well as deep gray matter structures,
such as nuclei of the thalamus and hypothalamus. The ill-
ness is increasingly understood as a disorder of connectivity
in brain networks linking these regions (Leuchter et al., 2012).
Many of the mood and neurovegetative symptoms, as well as
deficits in cognition and memory, have been hypothesized to
arise from dysfunction in networks linking cortical and subcor-
tical gray structures (Ottowitz et al., 2002; Savitz and Drevets,
2009). Functional magnetic resonance imaging (fMRI) studies
of resting-state blood oxygen level-dependent (BOLD) signal
in MDD have shown overall increases in functional connec-
tivity in the default mode and other brain networks (Greicius
et al., 2007; Grimm et al., 2009; Sheline et al., 2010; Zhou
et al., 2010) with complex patterns of altered resting connec-
tivity between some cortical and subcortical structures (Bluhm
et al., 2009; Cullen et al., 2009; Veer et al., 2010; Hamilton et al.,
2011). Neurophysiologic studies using magnetoencephalography
(MEG) or quantitative electroencephalography (qEEG) also have
shown increased functional connectivity, as indicated primarily
by increased theta (4–8Hz) and alpha band (8–12Hz) ampli-
tude, power, coherence, and other measures of synchronized
brain activity (Henriques and Davidson, 1991; Bruder et al.,
1997; Debener et al., 2000; Knott et al., 2001; Pizzagalli et al.,
2005; Fingelkurts et al., 2007). Synchronized oscillations oper-
ate on a more rapidly shifting time scale than BOLD signals
(Britz et al., 2010) and oscillatory activity measured by qEEG has
been shown to elicit BOLD signal activations within resting state
networks (Musso et al., 2010). These studies highlight how mea-
sures of oscillatory activity and blood flow represent “two sides
of the same coin,” and are complementary indicators of brain
network activity.
MDD has been conceptualized as a syndrome of “thalamocor-
tical dysrhythmia,” marked by persistent resonance of rhythmic
thalamocortical activity during the waking state; other illnesses
in the family of thalamocortical dysrhythmias include central
pain syndromes, some epilepsies, and Parkinson’s Disease (Llinás
et al., 1999; Bish et al., 2004; Llinás and Steriade, 2006; Walton
et al., 2010; Schulman et al., 2011). Theta and alpha activity are
produced by the cerebral cortex under the strong influence of tha-
lamic pacemakers (Buzsáki and Draguhn, 2004). There are not
distinct populations pacemaker cells for the two frequency bands.
Overlapping thalamic cell populations generate alpha and theta
rhythms (c.f., Hughes and Crunelli, 2005), with the predominant
rhythm dependent upon their rate of firing, which is depen-
dent upon the activity of voltage dependent (T-type) calcium
channels (Perez-Reyes and Lory, 2006). In thalamocortical dys-
rhythmias, there appears to be hyperpolarization of thalamic relay
cells, with consequent de-inactivation of T-channels and persis-
tent low-threshold calcium spiking, and resultant monotonous
resonant low-frequency oscillations (Llinás et al., 1999; Llinás
and Steriade, 2006; Schulman et al., 2011). The increased oscilla-
tory synchrony in patients with MDD and other thalamocortical
dysrhythmias measured using MEG is pronounced in the theta
frequency band, but also is prominent in the alpha band and
across different frequency bands (Llinás et al., 1999; Schulman
et al., 2011). This finding of greatly increased oscillatory syn-
chrony usingMEG inMDD is consistent with reports of increased
thalamocortical connectivity using fMRI (Greicius et al., 2007)
and increased coherence across the frequency spectrum on qEEG
(Leuchter et al., 2012).
Increased oscillatory synchrony in MDD has been reported
in multiple frequency bands across brain regions (Fingelkurts
et al., 2006, 2007; Leuchter et al., 2012); most reports, however,
have highlighted increased alpha band synchrony (Henriques and
Davidson, 1991; Bruder et al., 1997; Debener et al., 2000; Knott
et al., 2001; Pizzagalli et al., 2005; Seagrave et al., 2010). The
most consistent findings have been local increases in power, and
therefore local synchrony, although the literature is mixed as
to specific locations where this has been reported. Disturbances
in frontal or posterior alpha power symmetry commonly have
been noted, but some studies have shown relatively greater
local alpha power and synchrony over left rather than right
anterior sites, others the opposite pattern, and still others find
primarily posterior differences (Tucker et al., 1981; Davidson
et al., 1987; Henriques and Davidson, 1991; Bruder et al.,
1997; Jin et al., 1997; Gotlib, 1998; Coan and Allen, 2004).
One report found that the pattern of frontal alpha asymme-
try fluctuated over the span of a few weeks in subjects with
MDD as compared with normal controls (Debener et al., 2000).
This finding suggests that the increased alpha band power
in MDD might best be viewed as indicating a broadly dis-
tributed, shifting state of brain dysregulation rather than a
fixed, localized abnormality (Fingelkurts et al., 2006; Park et al.,
2007).
Several studies have examined subjects during task activa-
tion, and these have yielded more consistent findings. Henriques
and Davidson (1997) compared alpha power in depressed sub-
jects with controls during verbal and spatial tasks. They found
that MDD subjects had a deficit in spatial task performance that
was associated with a deficit in modulation of right hemispheric
posterior alpha power. Manna et al. (2010) reported poor alpha
modulation in left and right hemispheres on verbal and spa-
tial tasks, respectively, when comparing anxious and non-anxious
depressed subjects. Most recently, Seagrave et al. (2010) found
that subjects with MDD were less able to desynchronize alpha
activity over the left hemisphere during a working memory task
than were normal controls. In a large study of subjects withMDD,
Leuchter et al. (2012) recently showed significant and widespread
increases in resting brain functional connectivity using qEEG
coherence. Increases in connectivity were seen across all frequency
bands, but most notably in the alpha band. Taken together, these
studies indicate a lack of normal modulation of brain function in
individuals with MDD.
The inability to modulate regional oscillatory activity, partic-
ularly in the alpha frequency band, in response to shifts in the
environment or task demands may represent a fundamental neu-
rophysiologic defect in MDD. Integration of brain activity across
greater distances is coordinated by lower frequency (e.g., alpha
or theta) activity, while shorter-distance coordination is coordi-
nated by higher frequency (e.g., beta and gamma, or 12–20Hz
and 20–40Hz activity, respectively) (Jann et al., 2009; Britz et al.,
2010; Sadaghiani et al., 2010). Synchronized alpha oscillations in
particular play a key role in global top-down control of brain cog-
nitive processes that have been shown to be disturbed in MDD
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(Klimesch et al., 2007; Sadaghiani et al., 2010). Synchronization of
oscillatory activity also may reflect, and be linked, to disturbances
in central serotonergic tone in MDD (Epstein et al., 2011).
Serotonergic projections from the medial septal region dampen
theta oscillatory synchrony in the hippocampus (Mu and Han,
2010), while those from the raphe to specific thalamic nuclei
modulate alpha synchrony (Kudina et al., 2004). Rhythmic oscil-
latory activity in qEEG has been shown to be modulated by
antidepressant medication (Feige et al., 2005; Dzirasa et al., 2010;
Mu and Han, 2010).
Another finding seen consistently across studies of subjects
with MDD is reduced rCBF broadly over the prefrontal cortex
(Awata et al., 1988; Videbech, 2000; Cintia, 2005). The defect
in modulation of alpha power and decreased rCBF appear to be
related phenomena, both being associated with severity of depres-
sive symptoms. The degree of decrease in cortical rCBF is corre-
lated with symptom severity (Awata et al., 1988; Mayberg, 1994;
Galynker et al., 1998), with the decrease most pronounced in
subjects with cognitive impairment associated with their depres-
sion (Dolan et al., 1994; Teneback et al., 1999). Similarly, the
severity of psychomotor retardation in MDD was found to be
correlated with the power of low frequency EEG, including in
the lower alpha band (Nieber and Schlegel, 1992). The abil-
ity to synchronize and desynchronize qEEG oscillations across
the frequency spectrum subserves a range of vital functions
within brain networks, from regulation of neurotransmitters to
cerebral blood flow. Dysregulation of cerebral oscillatory activ-
ity therefore may represent the pathophysiologic link between
disturbances in monoaminergic neurotransmission, cerebral per-
fusion, and brain network dysfunction in MDD (Leuchter et al.,
2012).
In considering disturbed brain oscillatory activity in MDD,
it is important to note that thalamocortical dysrhythmia may
represent either a “top-down” or “bottom-up” process (that is,
primarily arising from disturbed cortical or thalamic function)
(Llinás et al., 1999). Resonance in the alpha or theta frequency
bands is maintained by loops of cells in the cortex and thalamic
nuclei that function as part of thalamocortical circuits. Persistent
burst patterns of cell firing in thalamic nuclei essentially lock in
the resonant frequency through their interaction with the corti-
cal cell population. In Parkinson’s Disease and other illnesses of
primarily striatal origin, the dysrhythmia may originate primarily
in the thalamus, thus representing a bottom-up phenomenon; in
the epilepsies, the mechanism may be more top-down in origin,
the result of aberrant cortical input (Llinás et al., 1999; Schulman
et al., 2011). The essential pathophysiology of MDD remains
unknown, and the illness may arise from either “end” of the res-
onance loop or as the result of an interaction among different
cell populations. The neurophysiologic manifestations of the dys-
rhythmia, however, may be indistinguishable between bottom-up
and top-down situations (Llinás et al., 1999). And importantly,
from the standpoint of therapeutic effects of rTMS, exogenous
input into any portion of a resonance loop may affect the func-
tion of all components of the thalamocortical circuit, leading to
amelioration of symptoms in a range of illnesses marked by dys-
rhythmia (Llinás et al., 1999; Jeanmonod et al., 2003; Fuggetta and
Noh, 2012).
EFFECTS OF rTMS ON MOTOR SYSTEMS
Most of what is known regarding the effects of magnetic stim-
ulation on brain function has been learned from the effects of
rTMS on motor systems. While these effects are critically depen-
dent upon a variety of stimulation parameters, including neu-
roanatomical target, pulse repetition frequency, waveform type,
and field strength, among other factors, the effects on the motor
system of adjusting rTMS stimulus parameters are immediately
detectable. In addition, the neurophysiologic basis of effects on
the motor system is relatively well understood because generation
ofMEPsmay be sufficient to explain the effects of magnetic pulses
on the motor cortex (Zarkowski et al., 2006). For example, low
frequency stimulation over the primary motor cortex decreases
motor excitability, whereas high frequency stimulation increases
excitability (Fitzgerald et al., 2006). The waveform of the mag-
netic pulse also in part helps to determine its effect. rTMS using
monophasic rectangular pulses appears to activate a relatively
homogeneous population of neurons and its effects more readily
summate than biphasic rTMS, so that it has a stronger short-
term effect on motor cortical excitability than biphasic rTMS. In
contrast, biphasic rTMS activates a range of both excitatory and
inhibitory neurons and appears to exert a broader range of effects
than monophasic rTMS of similar amplitude (Arai et al., 2005;
Sommer et al., 2006; Lefaucheur, 2009).
THE EFFECTS OF rTMS ON MOOD SYSTEMS
While focal, high field strength stimulation over particular areas
of the motor strip affects contralateral limb movements, it
remains unclear what stimulation procedure is optimal to pro-
duce consistent therapeutic effects of rTMS on mood. Although
high frequency (10Hz) focal stimulation of the left DLPFC is
the most commonly used approach for the treatment of MDD
(Slotema et al., 2010), focal stimulation at high frequency in the
left and low frequency (1Hz) in the right DLPFC regions both
have been reported to be of significant benefit in relieving symp-
toms of depression (Gross et al., 2007). It is unknown whether
different foci of stimulation, simultaneous stimulation of mul-
tiple targets, or broader general stimulation may be of similar
or greater therapeutic benefit because these approaches have not
been studied systematically.
In contrast to the effects of rTMS on the motor system, its
effects in ameliorating symptoms of MDD commonly emerge
only over days or weeks of continued treatment sessions (Higgins
and George, 2009), so that systematic investigation of the many
different stimulus parameters is challenging. The processes by
which rTMS yields motor results may be distinct from those oper-
ative in using rTMS to treat depression. The laminar structure of
motor cortex and the vertical integration of the central motor sys-
tem are fundamentally different from the organization of brain
systems regulating mood. Mood regulatory pathways more dif-
fusely involve multiple areas of dorsolateral, medial orbital, and
medial prefrontal cortex, areas that have rich reciprocal intercon-
nections with each other and with deep gray matter structures.
The networks subserving mood regulation are not as well defined
as those involved in motor function and are more heterogeneous,
with patterns of aberrant regional metabolism in MDD varying
across individuals (Shafi et al., 2012). Synchronized oscillations
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play a prominent role in binding together the brain networks
that regulate both mood and motor activity. The nature of coor-
dinated oscillatory activity in the motor system, however, may
be fundamentally different from that in other brain networks in
terms of the frequency bands that play a prominent role as well
as the structures that are bound together by synchronous activ-
ity (van Wijk et al., 2012). There may be limitations to the extent
to which stimulus parameters that have immediate effects on the
motor strip (M1) produce optimal therapeutic effects in a dif-
ferent region (such as DLPFC) for the treatment of MDD (Rossi
et al., 2009; Hoogendam et al., 2010).
This problem of identifying optimal parameters for treat-
ment of MDD is further compounded by the fact that the
MOA underlying the effects of rTMS on mood and thinking in
MDD are incompletely understood (Pascual-Leone et al., 2000;
Fecteau et al., 2006; Rossi et al., 2009). While phenomena such as
muscle contraction following motor strip stimulation or visual
phosphenes following stimulation of occipital cortex or retina
can be explained through depolarization and neuronal firing, the
origins of more complex phenomena such as altering function
of cognitive or mood regulating systems is more challenging. It
has been proposed that rTMS can produce a functional “vir-
tual lesion” in underlying cortex, temporarily disrupting cognitive
processes reliant on that region (Pascual-Leone et al., 2000). Some
aspects of the effects of rTMS on the motor system, thinking,
and memory may be pertinent to understanding the therapeu-
tic benefit of rTMS onmood. The virtual lesion concept may help
explain the clinical effectiveness observedwith “slow rTMS” (1Hz
or lower frequencies) administered to the right DLPFC. Increased
relative cerebral blood flow and cortical excitability in this brain
region are thought to contribute to the symptoms of MDD, and
the inhibitory effects of low frequency rTMS may decrease right
DLPFC activity, leading to clinical improvement (Speer et al.,
2000; Kito et al., 2008; Rossini et al., 2010). Conversely, the left
DLPFC region has been reported to have low relative blood flow
and decreased cortical excitability in MDD, and “fast rTMS”
(e.g., 10Hz) has been suggested to contribute to a lasting elevation
in activity in this target region (Rossini et al., 2010).
CELLULAR AND NEUROCHEMICAL EFFECTS OF rTMS
IN MDD
Evidence indicates that the MOA of rTMS on depressed mood
may be understood in part through its ability to create enduring
effects on synaptic signaling. One line of research demonstrates
that rTMS has lasting effects on cortical plasticity (O’Reardon
et al., 2007; Cheeran et al., 2008; Gentner et al., 2008; George
et al., 2010; Oberman et al., 2010; Stagg et al., 2010; Freitas et al.,
2011). Neuroimaging studies have shown that, after a series of
rTMS treatments, activity is persistently increased not only in
DLPFC, the neuroanatomic target of stimulation, but also in sub-
genual anterior cingulate and basal ganglia regions, areas that are
synaptically connected to DLPFC but are not believed to be stim-
ulated directly because the magnetic field strength at that depth is
insufficient to trigger depolarization (Speer et al., 2000; Loo et al.,
2003; Kito et al., 2008). Given that multiple regions have been
implicated in the pathophysiology of depression (Boynton and
Olson, 1990), neuroplasticity involving multiple brain regions
linked through cortical-subcortical networks may underlie such
persistence of effect (Peinemann et al., 2004; Boggio et al., 2011;
Di Lazzaro et al., 2011; Freitas et al., 2011; Iezzi et al., 2011;
Pascual-Leone et al., 2011; Song et al., 2011; Nardone et al., 2012).
A second line of research demonstrates that rTMS also has
lasting effects on monoaminergic neurotransmission, including
alterations in the capacity for serotonin synthesis from trypto-
phan (Sibon et al., 2007), the release of dopamine (Strafella et al.,
2001; Pogarell et al., 2006), and the expression of frontal and
striatal adrenergic receptors (Ben-Shachar et al., 1999). There
appears to be a link between certain shifts in regional brain
activity and serotonergic tone in particular. Baeken et al. (2011)
examined the relationship between rTMS and regional post-
synaptic 5-HT(2A) receptor binding indices. They found that
improvement following left sided 10Hz rTMS treatment cor-
related positively with changes in 5-HT(2A) receptor binding
indices in the DLPFC bilaterally and negatively with right hip-
pocampal binding. Several small case series have implicated
genetic polymorphisms that affect serotonin transporter expres-
sion, the 5-HT(1A) receptor, or BDNF in modulating the like-
lihood of response to rTMS, but results have been inconsistent
(Zanardi et al., 2007; Bocchio-Chiavetto et al., 2008; Malaguti
et al., 2011). In one study, rapid tryptophan depletion did not
lead to reemergence of depressive symptoms in adults who had
responded to a course of rTMS (O’Reardon et al., 2007), suggest-
ing that the therapeutic effects of rTMS do not depend critically
upon central serotonergic tone.
Effects on neuroendocrine measures also have been reported
in animals (Keck et al., 2001; Hedges et al., 2003; Kito et al.,
2010) and in humans undergoing rTMS (Pridmore, 1999; Cohrs
et al., 2001; Zwanzger et al., 2003), and hippocampal neurogene-
sis has been reported in animals (Czeh et al., 2002). A cautionary
note about interpreting these animal studies has been sounded by
Lisanby and Belmaker (2000): while therapeutic rTMS in humans
tends to involve stimulation of a spatially-limited portion of brain
tissue, most if not all of the animal brain is exposed to high levels
of the magnetic field in these experimental paradigms, due to the
different size of animals and the physics of generating magnetic
fields.
CEREBRAL OSCILLATORY ACTIVITY AND THE MECHANISM
OF ACTION OF rTMS IN MDD
Observations regarding changes in cerebral neurotransmitter
levels and cortical plasticity and blood flow patterns (Paus
and Barrett, 2004) indicate that the MOA of rTMS is best
understood at the level of the brain as an organ system,
with neurochemical and neuroplastic changes seen in regions
that are far removed from the site of stimulation (Pogarell
et al., 2006; Sibon et al., 2007; Cho and Strafella, 2009).
In a study of cerebral blood flow following rTMS adminis-
tered to DLPFC, Paus et al. (2001) demonstrated that low-
frequency rTMS caused decreased blood flow not only in the area
being stimulated, but also in other regions including the ante-
rior cingulate cortex; conversely, high-frequency rTMS caused
increases blood flow in the same regions. These findings indi-
cate that rTMS modulates activity through distributed brain
networks.
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These findings beg the question, however, as to how
administration of repetitive rhythmic magnetic pulses induces
neuroplastic changes in these networks. Evidence indicates that
rTMS may be linked to alterations in neuroplasticity, neuro-
transmission, and blood flow through the effect of rTMS on
cerebral oscillatory activity. The most immediate effect of rTMS
on brain function is alteration of the oscillations of under-
lying brain tissue as measured with the electroencephalogram
(EEG). High-frequency stimulation (>5Hz) leads to an immedi-
ate synchronization of EEG activity in the alpha and beta bands,
consistent with entrainment of oscillatory activity (Paus et al.,
2001; Klimesch et al., 2003; Fuggetta et al., 2005, 2008; Brignani
et al., 2008; Hamidi et al., 2009; Johnson et al., 2010; Thut et al.,
2011); entrainment following stimulation also has been reported
in the delta and theta bands (Fuggetta and Noh, 2012). This
entrainment has been reflected in findings of increased power
(Fuggetta et al., 2005; Brignani et al., 2008; Fuggetta and Noh,
2012) and coherence (Fuggetta et al., 2008) particularly in the
alpha frequency band as assessed with EEG.
This pronounced and immediate entrainment of oscillatory
activity suggests that the modulatory activity of rTMS on brain
structures and circuits may be accomplished by altering the fre-
quency and patterns of brainwave oscillatory activity. A series
of studies has demonstrated that high frequency rTMS leads to
alterations of cortical oscillations at the site of stimulation, and
frequently at more distant areas as well, consistent with linkage of
brain regions through corticocortical and thalamocortical loops
(Fuggetta et al., 2005, 2008; Brignani et al., 2008; Hamidi et al.,
2009; Thut and Miniussi, 2009; Thut and Pascual-Leone, 2010).
Although the effect of high-frequency rTMS is to elicit local cor-
tical oscillations predominantly at the frequency of stimulation
for the duration of stimulation (Paus et al., 2001; Rosanova et al.,
2009), rTMS does not broadly entrain cortical rhythms to the
stimulation frequency on a sustained basis. Once stimulation has
ceased, rTMS appears primarily to enhance or “bias” the natu-
ral rhythms of underlying cortex (Hamidi et al., 2009; Johnson
et al., 2010). In fact, outside of the target area of immediate corti-
cal stimulation, rTMS evokes alpha activity in the occipital cortex,
beta activity in the parietal cortex, and beta/gamma activity in
the frontal cortex (Rosanova et al., 2009). In multiple experi-
mental paradigms, high frequency (10Hz) rTMS pulses appear
to trigger and reset oscillatory mechanisms (Paus et al., 2001;
Fuggetta et al., 2005, 2008; Brignani et al., 2008), marked by a
so-called “event related synchronization” (ERS) at the frequency
of stimulation in the area that has been stimulated, followed
rapidly by an “event related desynchronization” (ERD) and re-
emergence of endogenous rhythms (Jäncke et al., 2006; Zarkowski
et al., 2006; Brignani et al., 2008; Sauseng et al., 2008). One study
recently suggested that low frequency (1 or 5Hz) stimulation may
facilitate emergence of local endogenous rhythms by disrupting
persistent low frequency thalamocortical resonance phenomena
(Fuggetta and Noh, 2012). Regardless of the frequency of stimula-
tion, enhancement of the reemergence endogenous local cortical
and thalamocortical rhythms may be central to theMOA of rTMS
stimulation. rTMS may act through entraining oscillations to the
frequency of stimulation, thus resetting cortical and thalamo-
cortical oscillators and facilitating the reemergence of normal,
intrinsic oscillatory activity (Paus et al., 2001; Fuggetta et al.,
2005, 2008) (Figure 1).
NEW APPROACHES TO RESETTING THALMOCORTICAL
OSCILLATORS
It may be possible to enhance the effectiveness of rTMS as a treat-
ment for depression through application of our current under-
standing of the MOA of rTMS. MDD is a brain disorder marked
by widespread dysregulation of oscillatory synchrony (Leuchter
et al., 2012), and through resetting cortical and thalamocortical
oscillators, rTMS may ameliorate the symptoms of MDD (Paus
et al., 2001; Fuggetta and Noh, 2012). Evidence suggests that the
effectiveness of rTMS in resetting oscillators may be increased
through: (1) synchronization of rTMS to the individual alpha fre-
quency (IAF), (2) modification of field strength and the waveform
of stimulation, and (3) broadening the area of stimulation. Each
of these strategies is discussed in greater detail below.
SYNCHRONIZATION OF rTMS TO THE INDIVIDUAL ALPHA
FREQUENCY
Although a wide range of stimulation frequencies has been shown
to modulate brain function (Thut and Pascual-Leone, 2010),
therapeutic application of rTMS commonly has focused on stim-
ulation in the alpha frequency band (Thut et al., 2011; Veniero
et al., 2011). This is consistent with current understanding of the
role of alpha oscillatory activity, which now is conceptualized as
playing a key role in maintaining coordinated activity among cor-
tical areas and between the cortex and subcortical gray matter
structures (e.g., thalamus) (Buzsáki and Draguhn, 2004). There
is evidence that endogenous activity in the alpha band in partic-
ular may exert top-down control over broadly distributed brain
regions, allowing selective activation of brain areas with conse-
quent alterations in brain circuit function (Klimesch et al., 2007;
Benedek et al., 2011). Alpha frequency oscillations appear to be
particularly well suited to coordinating activities over distance
in the brain, in part because of the influence of thalamic pace-
makers (Buzsáki and Draguhn, 2004). Upper alpha band power
(10–12Hz), as measured with qEEG, is involved in modulating
connections among the dorsal anterior cingulate cortex, anterior
insula, anterior prefrontal cortex and thalamus (Sadaghiani et al.,
2010). Several of these brain areas are involved both in cogni-
tion and in regulation of mood. Alpha activity, particularly in the
lower band (8–10Hz), fulfills the function of an inhibitory oscil-
latory rhythm. A highly synchronous alpha state can bind brain
areas together in a preparatory manner in an ERS prior to their
involvement in a cognitive or motor task (Klimesch et al., 2007).
This inhibitory synchronized state is preparatory for the task that
follows because it facilitates recruitment of specific regions of cor-
tex for actual task involvement. The task execution itself is marked
by an ERD, or attenuation of synchronous alpha activity and
the emergence of largely asynchronous beta and gamma activity
(Klimesch et al., 2003; Brignani et al., 2008). Brain areas that are
in a highly synchronous alpha state frequently show high alpha
band power and low regional cerebral blood flow (rCBF), and
following an ERD show low alpha power and higher rCBF (Feige
et al., 2005). The effects of rTMS pulses on motor and cognitive
functions are complex, with some studies showing detrimental
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FIGURE 1 | Effects of rTMS stimulation on brain function. On average,
patients with MDD exhibit a broad pattern of highly synchronous theta and
alpha activity over most brain regions (A). rTMS administered as a train of
high amplitude pulses at a frequency of 10Hz entrains brain oscillatory
activity to the frequency of stimulation, for the duration of the stimulation
period (B). Multiple treatments over time may have the effect of resetting
cortical oscillators. Once oscillators are reset, regionally-specific
endogenous rhythms of the brain may reemerge. These consist of beta
and gamma activity in the frontal cortex, beta in the parietal cortex, and
alpha in the occipital cortex (C).
effects and others enhancement effects on task performance. This
appears to depend upon several factors including whether the
pulses are delivered before, during, or after the task (Hamilton
and Pascual-Leone, 1998; Wassermann et al., 1999; Evers et al.,
2001; Sparing et al., 2001; Klimesch et al., 2003; Brignani et al.,
2008; Hamidi et al., 2009).
Klimesch et al. (2003) have proposed that one key factor deter-
mining whether exposure to rTMS enhances or degrades task per-
formance is the relationship of the frequency of rTMS stimulation
to the subjects’ IAF. This group demonstrated rTMS delivered at
a subject’s IAF plus 1Hz (IAF + 1) enhanced performance on a
mental rotation task compared with pulses at a lower individual-
ized frequency (IAF − 3) or at a fixed, higher (20Hz) stimulation
frequency. Similarly, Hamidi et al. (2009) observed that among
subjects performing cognitive tasks in association with 10Hz
rTMS, those with higher IAF tended to have higher task perfor-
mance accuracy. A central role for modulation of IAF in the MOA
of rTMS is consistent with the increased understanding of the
importance of alpha frequency band activity in regulating brain
functions. Higher mean IAF is associated with greater rCBF at
rest, greater preparedness for external input, and greater neural
efficiency in task performance (Jann et al., 2010). In addition,
higher power and broadly synchronized alpha activity is associ-
ated with lower regional blood flow (Feige et al., 2005). Taken as
a whole, these findings indicate an association between aberrant
alpha activity, rCBF, and MDD severity, such that the aberrant
alpha activity may constitute one of the functional underpinnings
of network dysregulation in MDD.
Stimulation at an individual’s intrinsic alpha frequency can
lead to activation or inhibition of a brain region, and “tuning”
of rTMS to the IAF may enhance effectiveness of the proce-
dure. rTMS delivered at the IAF may be particularly effective
at resetting dysfunctional cortical oscillators, which may lead to
increased cerebral blood flow and therapeutic benefit in MDD.
No published study to date has systematically examined the
effects of rTMS pulses delivered at the actual IAF and a spread
of frequencies narrowly higher and lower the IAF; such studies
would be necessary to establish definitely a central role for IAF
as a target for the frequency of rTMS stimulation. Although no
treatment trials have specifically utilized treatment at the IAF, two
trials in schizophrenia have employed IAF stimulation. In the first
of these two trials, TMS delivered at the IAF demonstrated a sig-
nificantly larger therapeutic effect than TMS at other frequencies
(29.6% reduction in negative symptoms, vs.<9% for other stim-
ulation settings, p = 0.007) (Jin et al., 2006). In the later trial
(Jin et al., 2012) using sham-controlled conditions, TMS tuned to
the IAF produced a significantly greater clinical effect than sham,
regardless of whether delivered over frontal or parietal locations.
While one trial in MDD used information about the IAF to guide
rTMS stimulation frequency choice (Arns et al., 2010), the inves-
tigators compared personalized IAF+ 1 stimulation [as proposed
by Klimesch et al. (2003)] with stimulation at 10Hz, but did not
directly compare stimulation at IAF with stimulation at other
frequencies. They reported that stimulation at IAF + 1 was not
superior to stimulation at a fixed frequency of 10HZ, and that for
lower IAF (e.g., 8Hz), the individualized stimulation frequency
may have been less effective. It is important to note that this report
is based upon a small open-label case series, and that the treat-
ment was administered at IAF + 1 and not IAF. Further research
would be necessary to evaluate the therapeutic effectiveness of
rTMS delivered at the IAF.
MODIFICATION OF FIELD STRENGTH AND THE WAVEFORM
OF STIMULATION
In addition to the frequency at which rTMS is delivered, the field
strength and waveform used for stimulation are important treat-
ment variables. rTMS commonly is delivered utilizing a train of
high field strength (1.5–4 Tesla) pulses administered with an elec-
tromagnetic coil to a discrete brain region. Recent research has
examined the use of different coil sizes and configurations, and
devices that perform stimulation using multiple coils, to perform
more intense, focused, or deeper brain stimulation. Research on
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the use of different coils is ongoing (Deng et al., 2013), and a
detailed discussion is beyond the scope of this review.
The paradigm of intense focal stimulation is predicated in part
on the precedent of motor system stimulation, and in part on the
pathophysiology of MDD in which there is hypometabolism of
the left DLPFC. It is not clear, however, that high field strength
pulses administered to a specific location is necessary to obtain
the therapeutic effects of rTMS in the treatment of MDD. Recent
research suggests that the neurophysiologic effects of stimula-
tion can be achieved with low electromagnetic field potential.
Subthreshold rTMS (i.e., delivered without depolarizing neurons)
has been shown to affect alpha band power and coherence more
than superthreshold rTMS (Fuggetta et al., 2008). Furthermore,
extremely weak magnetic fields have been demonstrated to have
significant effects on waking EEG, most notably in the alpha band
(Cook et al., 2005, 2009). Low magnetic field strengths also have
been shown to affect cerebral glucose metabolism (Volkow et al.,
2010). These findings are consistent with recent work indicating
that low strength fields can strongly entrain action potentials of
cortical neurons through ephaptic coupling (Anastassiou et al.,
2011).
Weak sinusoidal waveforms have not been as extensively stud-
ied as havemonophasic or other biphasic waveforms, but research
indicates that they may be effective in altering brain function. In
an animal model, a weak sinusoidal magnetic field in conjunction
with a static field had significant effects on reducing EEG power
(Vorobyov et al., 1998). Sinusoidal waveform magnetic stimula-
tion produces sinusoidal electrical fields (EFs) in the brain. Weak
sinusoidal EFs have potent effects in entrainment of cortical oscil-
lations both in animals (Ozen et al., 2010) and in vitro (Francis
et al., 2003; Fröhlich and McCormick, 2010; Anastassiou et al.,
2011), as well as in modulating and biasing endogenous corti-
cal oscillations (Reato et al., 2010), even at subthreshold levels
that do not lead to neuronal depolarization and action potential
discharges.
The effects of low magnetic field stimulation both on EEG
and metabolism suggest that it may hold therapeutic promise
in MDD. The potential usefulness of these low field intensities
in treatment is supported by reports that low magnetic field
strengths may improve mood in patients with treatment-resistant
depression (Rohan et al., 2004; Carlezon et al., 2005; Rokni-Yazdi
et al., 2007; Martiny et al., 2010).
Application of transcranial alternating current stimulation
(tACS) also supports the concept that low energy sinusoidal wave-
forms may have therapeutic benefit. In this technique, low levels
of sinusoidal electrical current are administered across the skull
in order to alter brain activity in a large region of tissue without
evoking a seizure but with demonstrable behavioral and neuro-
physiologic effects (Paulus, 2011). Applying sinusoidal slow oscil-
lating transcranial potentials (0.75Hz) to healthy subjects during
early sleep, Marshall et al. (2006) demonstrated enhancement of
declarative memory and an associated increase in slow wave sleep,
endogenous cortical slow oscillations, and slow spindle activity in
the frontal cortex. This work demonstrates both entrainment of
cerebral oscillatory activity in humans using low-field potentials
and its functional effects. Using a brief (≤10min) application
of 10Hz tACS in healthy adults, administered at low current
(<0.5mA) over the primary motor cortex, researchers (Antal
et al., 2008) found significant improvements in the acquisition
and early consolidation phase of implicit motor learning in a
serial reaction time task. Recent behavioral work with tACS (at
a theta-band 6.5Hz frequency) applied to the left DLPFC led to
a riskier decision-making pattern compared with right DLPFC or
sham stimulation (Sela et al., 2012). In an examination of neuro-
physiologic effects, Zaehle et al. (2010) demonstrated the ability
of tACS to alter the EEG in healthy adults. In their work, tACS
was applied over the occipital regions, using a frequency personal-
ized to the IAF of each subject. They found that tACS elevated the
endogenous alpha power in the parieto-central region, whereas
sham stimulation did not. Frequencies other than IAF were not
examined. Their work demonstrated that tACS could produce
entrainment of brain rhythms, but these projects did not study
clinical or behavioral effects in depressed population. This line of
work supports the value of further research into the use of low
energy sinusoidal waveform stimulation of the brain in MDD.
There are other forms of low-intensity brain stimulation,
including “cranial electrotherapy stimulation” (CES). The phys-
iologic effects of this and other methods of stimulation have not
been the subject of systematic study. The extent to which CES cur-
rent enters the brain and its possible effects on brain function and
mood are not well documented or understood.
BROADENING THE AREA OF STIMULATION
Entrainment of cerebral oscillatory activity appears to be an
essential step in resetting cortical oscillators. The customary
approach to rTMS is to apply stimulation to a single target, most
commonly over the right or left DLPFC. As discussed above,
stimulation to a single target area can have neurophysiologic
and neuroplastic effects in distant areas connected through brain
networks. An alternative to targeting a specific mood regulating
area is to stimulate the brain broadly. A procedure to adminis-
ter low-field magnetic stimulation to large areas of the brain has
been described by Phillips and Jin (2012). This procedure uti-
lizes a device that contains three cylindrical neodymium magnets
positioned close to the scalp distributed along the midline from
the prefrontal to the parietal region. The magnets are rotated
at a programmable frequency, generating a sinusoidal magnetic
waveform that imparts stimulation along the parasagittal line
(Figure 2). A preliminary feasibility study of 45 subjects treated
with low-field sinusoidal magnetic stimulation synchronized to
the IAF (synchronized TMS, or sTMS) showed that 44.8 % of
subjects responded to the treatment, significantly greater than
the proportion responding to sham treatment (Phillips and Jin,
in submission). It has not yet been demonstrated that sTMS is
superior to rTMS, and a multi-center double-blind controlled
clinical trial to investigate the safety and effectiveness of sinu-
soidal magnetic fields delivered at the patient’s IAF to treat MDD
is currently being conducted by NeoSync, Inc (ClinicalTrials.gov
Identifier NCT01370733).
CONCLUSION
Converging lines of evidence indicate that MDD is linked to alter-
ations in cerebral blood flow, metabolism, and regulation of neu-
ronal oscillatory activity. These abnormalities in brain physiology
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FIGURE 2 | Effects of sTMS stimulation on brain function. On
average, patients with MDD exhibit a pattern of highly synchronous
theta and alpha activity seen broadly over most brain regions (A).
The low-amplitude sinusoidal stimulation provided by the neodymium
magnets rotating at the IAF entrains brain oscillatory activity to the
frequency of stimulation for the duration of the stimulation
period (B). Like the high amplitude pulses of rTMS, multiple
treatments of subthreshold sinusoidal stimulation may have the
effect of resetting cortical oscillators. Once oscillators are reset,
regionally-specific endogenous rhythms of the brain may reemerge.
These consist of beta and gamma activity in the frontal cortex,
beta in the parietal cortex, and alpha in the occipital cortex (C).
are reflected in the severity of mood disturbance, neurovegeta-
tive symptoms, and cognitive dysfunction. Disturbed oscillatory
activity is most clearly evident in the alpha frequency band, where
qEEG detects disturbances in power and coherence.
The disturbance in regulation of alpha activity is consistent
with the effectiveness of alpha frequency rTMS in the treat-
ment of MDD. rTMS administered in the alpha frequency band
promotes immediate ERS followed by ERD. Over time, this
repetitive entrainment of cerebral oscillators may represent the
MOA for rTMS in the treatment of MDD. Entrainment of cere-
bral oscillations by exogenous stimulation serves to reset cortical
oscillators, possibly enhancing neuroplasticity, normalization of
cerebral blood flow, and amelioration of depressive symptoms.
Specific modifications of the rTMS methods that are cur-
rently employed in clinical practice could lead to enhanced
efficacy of the technique for treatment of depression. First,
administration of alpha frequency rTMS that is synchronized
to the patient’s IAF should be evaluated as an alternative to
fixed-frequency 10Hz rTMS, a widely employed setting and
the one which has been approved by the US Food and Drug
Administration for therapeutic use. Data suggest that ERS
and resetting of cortical oscillators may be most effectively
achieved by stimulation at the oscillatory frequency that is spe-
cific for each individual. Second, subthreshold sinusoidal wave-
form magnetic stimulation may be as effective, if not more
effective, at resetting cortical oscillators as high-field electro-
magnetic stimulation. Low field stimulation may be not only
be as effective, but could be better tolerated by patients. Third,
because alpha dysregulation in MDD is widespread across brain
regions, it is possible that stimulation administered to the
brain more broadly, may be at least as effective as stimulation
delivered to the conventional DLPFC target in ameliorating
the symptoms of MDD. Future studies of the effectiveness of
brain stimulation therapies should examine not only ameliora-
tion of depressive symptoms, but also improvements in cogni-
tion and functional status, as cognitive and functional deficits
are common features of the syndrome of MDD. Tailoring of
the method of delivery of rTMS to improve the effective-
ness with which cortical oscillators are reset may more effec-
tively normalize neurophysiologic abnormalities in subject with
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